@article{3047608,
    title = "SUCCESSFUL USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN A PREGNANT WOMAN
WITH LUPUS NEPHRITIS",
    author = "KONTESSIS, PS and PARASKEVOPOULOS, A and PAPAGEORGIOU, I and RAPPINI, P and and DIGENIS, GE and ANTSAKLIS, A and ZEREFOS, N",
    journal = "American Journal of Kidney Diseases",
    year = "1995",
    volume = "26",
    number = "5",
    pages = "781-784",
    publisher = "W B SAUNDERS CO LTD",
    issn = "0272-6386, 1523-6838",
    doi = "10.1016/0272-6386(95)90442-5",
    keywords = "ERYTHROPOIETIN; PREGNANCY; LUPUS NEPHRITIS",
    abstract = "Recombinant human erythropoietin (r-HuEPO) is broadly accepted as
treatment for anemia in dialysis and nondialysis patients with chronic
renal failure, but data regarding the safety and efficacy of this drug
in pregnancy are limited. Maternal and fetal problems have been reported
to be associated with anemia during pregnancy, On the other hand, anemia
is a frequent feature of systemic lupus erythematosus. We report the
successful use of r-HuEPO in a young woman with lupus nephritis
complicated by severe anemia during pregnancy, Additional studies should
be encouraged to confirm the safety of r-HuEPO therapy during pregnancy.
(C) 1995 by the National Kidney Foundation, Inc."
}